This website use cookies and similar technologies to improve the site and to provide customised content and advertising. By using this site, you agree to this use. To learn more, including how to change your cookie settings, please view our Cookie Policy
Pocketmags Digital Magazines
Pocketmags Digital Magazines
   You are currently viewing the European Union version of the site.
Would you like to switch to your local site?
Digital Subscriptions > Development Finance > Issue 5 > New business model drives successful trials of Ebola vaccine

New business model drives successful trials of Ebola vaccine

A woman and child at an Ebola vaccination campaign in Liberia
© UNMEER/Aalok Kanani

Gavi, an international vaccine organisation and large stakeholder in the development of the latest Ebola vaccine, has said the successful trial of a drug certified by the World Health Organization in December 2016 would not have been possible without public and private sector investment.

Purchase options below
Find the complete article and many more in this issue of Development Finance - Issue 5
If you own the issue, Login to read the full article now.
Single Issue - Issue 5

View Issues

About Development Finance

Leaders with impact How Europe is leveraging the private sector for development -Why fair taxation should be a development goal -Could wealthy millennials become impact investors? -Zambia praises IFC over new solar programme

Other Articles in this Issue